MediVet Biologics Launches Innovative Immunotherapy Trial for Canine Cancer – Benzinga
|
MediVet Biologics Launches Innovative Immunotherapy Trial for Canine Cancer
Benzinga K9ACV is a service provided by MediVet Biologics which allows for an affordable personalized immunotherapy vaccine for canine cancer. The immunotherapy cancer vaccine was developed by MediVet Biologics in partnership with researchers from the … |
